Oncology Unit 1, Veneto Institute of Oncology IOV-IRCCS, 35128 Padua, Italy.
Postgraduate School of Diagnostic and Interventional Radiology, University of Milan, 20122 Milan, Italy.
Int J Mol Sci. 2023 Aug 11;24(16):12681. doi: 10.3390/ijms241612681.
Despite the advances made in treatment, the prognosis of pancreatic ductal adenocarcinoma (PDAC) remains dismal, even in the locoregional and locally advanced stages, with high relapse rates after surgery. PDAC exhibits a chemoresistant and immunosuppressive phenotype, and the tumor microenvironment (TME) surrounding cancer cells actively participates in creating a stromal barrier to chemotherapy and an immunosuppressive environment. Recently, there has been an increasing use of interventional radiology techniques for the treatment of PDAC, although they do not represent a standard of care and are not included in clinical guidelines. Local approaches such as radiation therapy, hyperthermia, microwave or radiofrequency ablation, irreversible electroporation and high-intensity focused ultrasound exert their action on the tumor tissue, altering the composition and structure of TME and potentially enhancing the action of chemotherapy. Moreover, their action can increase antigen release and presentation with T-cell activation and reduction tumor-induced immune suppression. This review summarizes the current evidence on locoregional therapies in PDAC and their effect on remodeling TME to make it more susceptible to the action of antitumor agents.
尽管在治疗方面取得了进展,但胰腺导管腺癌(PDAC)的预后仍然不容乐观,即使在局部和局部晚期阶段,手术后复发率也很高。PDAC 表现出化学抗性和免疫抑制表型,并且癌细胞周围的肿瘤微环境(TME)积极参与形成化疗的基质屏障和免疫抑制环境。最近,越来越多地使用介入放射学技术来治疗 PDAC,尽管它们不是标准的治疗方法,也不包含在临床指南中。局部方法,如放射治疗、热疗、微波或射频消融、不可逆电穿孔和高强度聚焦超声,对肿瘤组织发挥作用,改变 TME 的组成和结构,并可能增强化疗的作用。此外,它们的作用可以通过 T 细胞激活增加抗原释放和呈递,并减少肿瘤诱导的免疫抑制。这篇综述总结了 PDAC 局部治疗的最新证据及其对重塑 TME 以使其更容易受到抗肿瘤药物作用的影响。